Skip to main content
. 2012 May 28;2012:894215. doi: 10.1155/2012/894215

Figure 1.

Figure 1

Progress of liver transplant recipients through the phases of the randomized study comparing a tacrolimus-based protocol with and without steroids. The rate of study completion was lower with TAC/DAC than with TAC/STR. Most commonly, patients in the TAC/DAC arm prematurely discontinued the study due to an adverse event. TAC: tacrolimus; DAC: daclizumab; STR: steroids; FAS: full analysis set; PAS: primary analysis set.